Methods: A retrospective analysis was conducted on clinical records of patients with a probable diagnosis of Parkinson's disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and Corticobasal Degeneration (CBD), all of whom underwent NfL testing in CSF and/or serum. The gene discussed is NEFL; the disease is multiple system atrophy.